Synthesis and biological evaluation of tripeptide derivatives of Cbz-Gly-Leu-Trp-OBzl(CF3)2 as NK1/NK2 ligands

International Journal of Peptide Research and Therapeutics

Volumn 6, Issue 4, 1999, Pages 255-262

  Millet, Régis ^a   Goossens, Jean François ^b   Bertrand Caumont, Karine ^c   Houssin, Raymond ^a   Hénichart, Jean Pierre ^a  

^a Universite de Lille   (France)

^b UNIV LILLE   (France)

^c UCB PHARMA   (Belgium)

Author keywords

Neurokinin A; Substance P; Tachykinins

Indexed keywords

EID: 53149122901     PISSN: 15733149     EISSN: 15733904     Source Type: Journal    
DOI: 10.1007/BF02443514     Document Type: Article

References (23)

1. a. McLean, S., Med. Res. Rev., 16 (1996) 297.
2. b. Lowe, III, J.A. and Snider, R., Annu. Rep. Med. Chem., 28 (1993) 99.
3. c. Lundberg, J.M., Can. J. Physiol. Pharmacol., 73 (1995) 908.
4. d. Maggi, C.A., Giachetti, A., Dey, R.D. and Said, S.I., Physiol. Rev., 75 (1995) 277.
5. e. Piedimonte, G., Exp. Lung. Res., 21 (1995) 809.
6. f. Quartara, L. and Maggi, A., Neuropeptides, 31 (1997) 537.
7. g. Quartara, L. and Maggi, A., Neuropeptides, 32 (1998) 1.
8. Chang, MM., Leeman, S.E. and Niall, H.D., Nat. New Biol., 232 (1971) 86.
9. Guard, S. and Watson, S.P., Neurochem. Int., 18 (1991) 149.
10. a. Burkholder, T.P., Kudlacz, E.M., Le, T.B., Knippenberg, R.W., Shatzer, S.A., Maynard, G.D., Webster, M.E. and Morgan, S.W., Bioorg. Med. Chem. Lett., 6 (1996) 951.
11. b. Burkholder, T.P., Kudlacz, E.M., Maynard, G.D., Liu, W.G., Le, T.B., Webster, M.E., Morgan, S.W., Wenstrup, D.L., Freund, D.W., Boyer, F., Bratton, L., Gross, R.S., Knippenberg, R.W., Logan, D.E., Jones, B.K. and Chen, T.M., Bioorg. Med. Chem. Lett., 7 (1997) 2531.
12. c. Kudlacz, E.M., Shatzer, S.A., Knippenberg, R.W., Logan, D.E., Poirot, M., Van Giersbergen, P.L.M. and Burkholder. T.P., J. Pharmacol. Exp. Ther., 277 (1996) 840.
13. d. Kudlacz, E.M., Knippenberg, R.W., Logan, D.E. and Burkholder, T.P., J. Pharmacol. Exp. Ther., 279 (1996) 732.
14. e. Kudlacz, E.M., Knippenberg, R.W., Shatzer, S.A. and Kenne, J.H., J. Auton. Pharmacol., 17 (1997) 109.
15. a. Maggi, C.A., Pharmacol. Res., 33 (1996) 161.
16. b. Barnes, P.J., Lancet, 8475 (1986) 242.
17. c. Barnes, P.J., Am. Rev. Resp. Dis., 143 (1991) S28.
18. d. Barnes, P.J., Belvisi, M.G. and Rogers, D.F., Trends Pharmacol. Sci., 11 (1990) 185.
19. Bertrand, C. and Geppeti, P., Trends Pharmacol. Sci., 17 (1996) 255.
20. Millet, R., Goossens, J.F., Bertrand-Caumont, K., Chavatte, P., Houssin, R. and Hénichart, J.P., Lett. Pept. Sci., 6 (1999) 221.
21. Cascieri, M.A., Ber, E., Fong, T.M., Sadowski, S., Bansal, A., Swain, C., Seward, E., Frances, B., Burns, D. and Strader, C.D., Mol. Pharmacol., 42 (1992) 458.
22. Gross, E. and Meienhofer, J. (Eds). The Peptides, Analysis, Synthesis, Biology, Vols. 1, 2, 3, 5, Academic Press, New York, NY, 1979-1983.
23. Britten, A. and Lockwood, G., J. Chem. Soc., Perkin Trans. 1, (1974) 1824.